Further, due to the tissue-specific CaSR-mediated signaling pathways, patients with FHH can manifest uncommon complications like pancreatitis, osteomalacia, and nephrolithiasis (24,25,26) that are not expected in this otherwise benign condition. Here, CASR is linked to osteomalacia.